Anti-Mouse PD-L1 (B7-H1) [10F.9G2] In Vivo Antibody - Ultra Low Endotoxin

(No reviews yet) Write a Review
SKU:
IVMB0096
Product Type:
In Vivo Monoclonal Antibody
Clone:
10F.9G2
Protein:
PD-L1
Isotype:
Rat IgG2b kappa
Reactivity:
Mouse
Synonyms:
Programmed Death Ligand 1
B7-H1
PD-L1
CD274
Research Area:
Immune Checkpoint & Cancer Biology
Endotoxin Level:
Ultra Low Endotoxin
Host Species:
Rat
Applications:
Blocking
CODEX
FA
IHC FF
WB
Frequently bought together:

Description

system_update_altTechnical Datasheet
Product Name:Anti-Mouse PD-L1 (B7-H1) [10F.9G2] In Vivo Antibody - Ultra Low Endotoxin
Product Code:IVMB0096
Size:1mg, 5mg, 25mg, 50mg, 100mg
Clone:10F.9G2
Protein:PD-L1
Product Type:Monoclonal Antibody
Synonyms:Programmed Death Ligand 1, B7-H1, PD-L1, CD274
Isotype:Rat IgG2b κ
Reactivity:Mouse
Immunogen:Mouse CD274
Applications:B, FA, IHC FF, PhenoCycler®, WB
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Endotoxin Level:<0.5 EU/mg as determined by the LAL method
Purity:≥98% monomer by analytical SEC
>95% by SDS Page
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Product CodeProduct NameEndotoxin Level
IVMB0095Anti-Mouse PD-L1 (B7-H1) [10F.9G2] In Vivo Antibody - Low EndotoxinLow
IVMB0096Anti-Mouse PD-L1 (B7-H1) [10F.9G2] In Vivo Antibody - Ultra Low EndotoxinUltra Low
Applications:B, CODEX®, FA, IHC FF, WB
Reactivity:Mouse
Host Species:Rat
Specificity:Clone 10F.9G2 recognizes an epitope on mouse PD-L1.
Antigen Distribution:PD-L1 is present on T cells, B cells, NK cells, dendritic cells, IFN-γ activated endothelial cells, and monocytes.
Immunogen:Mouse CD274
Concentration:≥ 5.0 mg/ml
Endotoxin Level:<0.5 EU/mg as determined by the LAL method
Purity:≥98% monomer by analytical SEC
>95% by SDS Page
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

PD-1 is a 50-55 kD member of the B7 Ig superfamily. PD-1 is also a member of the extended CD28/CTLA-4 family of T cell regulators and is suspected to play a role in lymphocyte clonal selection and peripheral tolerance. The ligands of PD-1 are PD-L1 and PD-L2, and are also members of the B7 Ig superfamily. PD-1 and its ligands negatively regulate immune responses. PD-L1, or B7-Homolog 1, is a 40 kD type I transmembrane protein that has been reported to costimulate T cell growth and cytokine production. The interaction of PD-1 with its ligand PD-L1 is critical in the inhibition of T cell responses that include T cell proliferation and cytokine production. PD-L1 has increased expression in several cancers. Inhibition of the interaction between PD-1 and PD-L1 can serve as an immune checkpoint blockade by improving T-cell responses In vitro and mediating preclinical antitumor activity. Within the field of checkpoint inhibition, combination therapy using anti-PD1 in conjunction with anti-CTLA4 has significant therapeutic potential for tumor treatments. PD-L2 is a 25 kD type I transmembrane ligand of PD-1. Via PD-1, PD-L2 can serve as a coinhibitor of T cell functions. Regulation of T cell responses, including enhanced T cell proliferation and cytokine production, can result from mAbs that block the PD-L2 and PD-1 interaction.

Technical Datasheet:View
Protein:PD-L1
Ligand/Receptor:PD-1 (PDCD1)
Research Area:Cancer, Costimulatory Molecules, Immunology
Product Thumbnail
Rat IgG2b Isotype Control
Clone 1-2
Isotype Rat IgG2b kappa
Endotoxin Level Ultra Low Endotoxin
Learn More

0 Reviews

View AllClose

Related Products